Prolific Machines, a biotech company, has raised $86.5 million in funding to develop a platform that uses light to control cells and grow biological products. The company aims to create a more efficient and sustainable way to produce everyday products, such as food and medicine.
The current method of cellular biology is expensive, inefficient, and imprecise. Prolific Machines’ platform uses light and artificial intelligence to control cells and optimize performance. This approach has the potential to revolutionize biotechnology and create new biosolutions.
“We set out with a vision to use one of our most abundant resources – light – to create an exponentially better way to control biology. I’m beyond proud of our team for making this vision a reality. We have proven that we can successfully control several cellular processes using light. This enables unparalleled control in both the space and the time axes, and this control is critical to making cheaper and higher quality products. I’m thrilled to be introducing the platform we have built to the world, and I’m excited to see all the different ways our partners will use it. We have only scratched the surface of what’s possible with our technology,” said Prolific Machines Co-Founder and CEO, Deniz Kent, PhD. “We have an incredible group of investors and commercial partners joining us to scale our impact. Stay tuned for some big announcements from us in the months ahead.”
The company plans to partner with other companies to commercialize its platform and will announce these partnerships in the coming months. The first applications of this technology will include the production of high-value bioproducts, such as nutritional proteins and antibodies.
”We are excited about Prolific Machines’ potential to dramatically lower the costs of producing biologics such as protein therapeutics, vaccines, and engineered antibodies,” said Eugene Chiu, Senior Partner at IQT. “Scalable biomanufacturing is vital to the continuous supply of medicines and medical countermeasures that can be crucial for health and biosecurity for the nation and the world.”
